Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Alan Meds vs Silhouette MD

Alan Meds
Graded #98

Higher grade

vs+1.6999999999999886
Silhouette MD
Graded #123

Lower grade

The verdict

Alan Meds takes it — 71.1/100 to 69.4/100, but only just.

Alan Meds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Telehealth platform offering compounded semaglutide and tirzepatide with multiple administration formats including microdosing and oral options. Silhouette MD is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueSilhouette MD +2
72
74
Dose & formulationEven
75
75
Clinical oversightAlan Meds +5
82
77
Labs & monitoringSilhouette MD +1
53
54
FulfillmentAlan Meds +11
78
67
Contract termsEven
55
55
Alan Meds · left barSilhouette MD · right bar

The numbers

MetricAlan MedsSilhouette MD
WeighScore71.1/10069.4/100
GradeCC
Scorecard rank#98#123
Semaglutide$158/mo (compounded)$149/mo (compounded)
Tirzepatide$295/mo (compounded)$299/mo (compounded)
Coverage46 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesYes
Alan Meds

Graded #98 · C

Strengths

  • Aggressively low monthly pricing
  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access
  • Multiple administration formats

Where it loses points

  • Limited public information on program details
Silhouette MD

Graded #123 · C

Strengths

  • Compounded semaglutide and tirzepatide in both injectable and oral formulations
  • Concierge-level support — monitoring, expert guidance, and check-ins included on every plan
  • Transparent, published pricing starting at $149/mo for semaglutide injection
  • Prescriptions issued and fulfilled by licensed clinical partner OpenLoop Health

Where it loses points

  • Tirzepatide ($299/mo) and oral options ($263–$325/mo) priced above many compounded competitors
  • State availability not published
  • Newer brand with limited independent review history
  • Medications are compounded, not FDA-approved brand-name

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard